![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi4FZ_03EWAqSqVhJ_k4Wsm4g2hY2DHvNDnT68_BRCfzx4qzWqdNqAoB1lo7Mr1Lv3060vHsC0NT4n3MYsrMs4lfmC0FPxsVjwWXadJmjAJhiVHW4Kgg1C5Y5X1b9LFWJM4qIBDXIcDNPE/s1600/syncardia.jpg)
SynCardia Systems (TAHT) filed for an initial public offering of 2.5 million shares, to raise up to $30 million. The medical technology company, which makes temporary artificial hearts, expects the IPO to price between $10 and $12 a share. SynCardia has applied to have its stock listed on the Nasdaq Global Market under the ticker symbol "TAHT." Roth Capital Partners is the sole book-running manager of the IPO, while Maxim Group and Monarch Capital Group are co-managers. If the underwriters exercise options to purchase additional shares, SynCardia could raise up to $34.5 million. The company plans to use the proceeds from the IPO for research and development, for sales and distribution, to pay down debt and for general corporate purposes.
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjTvZyzSXIUVaUkYVQGLVAJ5YT5s5MItmUmXCh_PhLNE6mxNuSfZ70b1BX50mTPa8GkxFNokE6QU_vv9fwDQ_kQ_1MkZSq-OA56gtNu4-cJDP5cEm3w8OaYPuGktFE41cT5D8ttkrqiziM/s1600/unnamed.jpg)
No comments:
Post a Comment